Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIIP vs NPH in Insulin-Naïve Type 2 Diabetes
NCT00490854Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2007
- Primary completion
- May 2008
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin human in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Mean change in Hemoglobin A1c at 76 weeks. Started Jul 2007; status: completed.
02
Drugs
insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00490854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490854.